Coronary Interventions Monthly eNewsletter
August 2023
Sales Competition is Heating Up!
Congrats to the Upper Midwest team for winning the regional award prior to month end! Look for continued updates on the competition every Monday, Wednesday and Friday.
Fun Facts
– 1,770,040 units sold globally since inception
– $596,244,2873.41 in revenue since inception
– $69,768,248.08 in 2022 global revenue
– 78 countries with regulatory clearance for GuideLiner™ Catheter
– 1,650 miles of guide extension sold since inception
GuideLiner™ Coast™ and V3 Resources
– GuideLiner™ Coast™ Sell Sheet
– GuideLiner™ Catheter Family Brochure
– GuideLiner™ Coast™ IFU
#1 7 fr. TrapLiner™ has cleared backorder and will likely continue rolling backorder through August!
#2 Guidewire 7327 is undergoing discontinuation. Affected customers should be notified. Please reach out to Lexxus (Betts) Keyes for a copy of the communication.
#3 Guardian™ 8215 is currently on a rolling backorder. Please look out for additional communication regarding the timeline for replenishment.
CVI 2023 was a remarkable opportunity for Teleflex Interventional to standout as the expert within the industry. Throughout the event, our team demonstrated exceptional dedication and enthusiasm by engaging with attendees, promoting our products, and answering questions. We look forward to capitalizing on the momentum gained and continuing to expand our influence in the market.
Congratulations to Vinnie Pompeo for working with Mount Sinai Medical Center in NYC and converting sales to the GuideLiner™ Catheter Family following the launch of GuideLiner™ Coast™. Historically, Mount Sinai Medical Center in NYC has been dedicated to a competitive product for their guide extension needs. This is a great GuideLiner™Catheter Family win!
Global Commercial Product Manager, Interventional
P: 919.370.6636
E: lexxus.betts@teleflex.com
*The statements above reflect the personal experiences and opinions of the physicians.
*This information is provided for education purposes and is not intended to be a substitute for sound clinical judgment or decision making, or professional experience relative to diagnostic and treatment options of a specific patient’s medical condition. Refer to package insert provided with the product for complete warnings, indications, contraindications, precautions, potential complications and instructions for use.
CAUTION: Federal (USA) law restricts these devices to sale or use by or on the order of a physician.
Teleflex, the Teleflex logo, Coast, Guardian, GuideLiner, and TrapLiner are trademarks or registered trademarks of Teleflex Incorporated or its affiliates in the U.S. and/or other countries. Other names are trademarks of their respective owners. Refer to the Instructions for Use for a complete listing of the indications, contraindications, warnings, and precautions. Information in this document is not a substitute for the product Instructions for Use. Not all products may be available in all countries. Please contact your local representative.
© 2023 Teleflex Incorporated. All rights reserved. Revised 8/2023.
Would you like Teleflex Interventional to send you emails containing product news and company information? You may revoke this permission at any time by emailing InterventionalMarketingTeam@teleflex.com.
*You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.
By clicking submit below, you consent to allow Teleflex Interventional to store and process the personal information submitted above to provide you the content requested.